Diabetes and COVID19: a bidirectional relationship.

Area of Science:

• Endocrinology
• Infectious Diseases
• Public Health

Background:

• The COVID-19 pandemic highlighted the impact of comorbidities like diabetes on disease outcomes.
• Hyperglycemia, regardless of cause, is linked to severe COVID-19, including respiratory distress, ICU admission, and mortality.

Purpose of the Study:

• To examine the relationship between diabetes, hyperglycemia, and COVID-19 outcomes.
• To understand how COVID-19 affects glucose metabolism and diabetes management.
• To review the implications of public health measures on diabetes care during the pandemic.

Main Methods:

• Review of existing literature on COVID-19 and diabetes.
• Analysis of clinical data linking hyperglycemia to COVID-19 severity.
• Assessment of viral impact on pancreatic function and metabolic control.
• Evaluation of treatment strategies for diabetic patients with COVID-19.

Main Results:

• Diabetes itself does not increase COVID-19 infection risk.
• Hyperglycemia is a significant predictor of worse COVID-19 outcomes.
• COVID-19 can trigger new-onset diabetes and exacerbate pre-existing diabetes through direct viral effects, inflammatory responses, and medication side effects.
• Pandemic-related restrictions can negatively affect diabetes self-management and access to care.

Conclusions:

• Effective management of hyperglycemia is crucial for improving COVID-19 outcomes in diabetic patients.
• COVID-19 poses a dual threat to individuals with diabetes, affecting both infection risk and metabolic control.
• Adaptations in diabetes care, including preferred use of insulin in severe cases, are necessary during the pandemic.